Questions to be answered now....not in seven weeks time, page-6

Here is a start:

DEP
1. What are the preliminary results from the DEP docetaxel + gemcitabine trial for pancreatic cancer? How many have been treated? What results have been seen when used as 1st line treatment? It has been over a year since the trial commenced and to date no results have been announced.
2. The company has suggested that commercial deals could very well be signed before completion of Phase 2 trials for ? DEP irinotecan. Why has no deal been signed? The company has said results are encouraging..Why the gap between "encouraging" and no commercial agreement?
3.

SPL7013
1. Why have trials for SPL 7013 as eye drops for viral infections not been done?
2. Why have phase 2 and 3 trials not been run for Viraleze?
3. Specifically, why has the company insisted on not changing the packaging of Viraleze in the UK unless forced to? Why is some unknown principle more important than (1) contributing to the health of the general public, and (2) what is this principle that is so important so as to damage shareholder value?
4. Why has no commercial agreement been signed in India for the distribution of Viraleze? The company suggested that this was imminent.

AstraZeneca
1. Why have no more agreements been signed to proceed to clinical trials? And please, don't say it is up to AZ. Sure, but are the results truly compelling?

Remuneration
1. Are the CEO and the VP for Business Development willing to only be compensated as a function of actual share price? Are they willing to take no further compensation until share price reaches ?? say $5.00?
2. Is the BOD willing to totally change the approach to performance rights? The granting of performance rights for "progress" that never leads to actual commercialization has only served to enrich management at the expense of shareholder value. An exception to this would be the VP of Research.
3. Is the BOD willing to take no further compensation until there is true commercial success. All the qualifications listed have not resulted in profitability.